Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	103.34	83.01	98.43	156.15	59.77	168.2
Short-Term Investments	229.26	315.97	368.63	311.14	230.69	42.01
Cash & Short-Term Investments	332.6	398.98	467.07	467.29	290.47	210.21
Cash Growth	-42.47%	-14.58%	-0.05%	60.88%	38.18%	113.13%
Other Receivables	-	6.46	-	-	-	-
Receivables	-	6.46	-	-	-	-
Prepaid Expenses	9.64	9.23	13.12	7.18	6.1	2.07
Total Current Assets	342.24	414.67	480.19	474.47	296.56	212.28
Property, Plant & Equipment	1.54	2.35	3.53	5.3	0.08	0.13
Long-Term Investments	140	204.44	-	80.88	140.4	-
Other Long-Term Assets	0.36	0.37	0.46	0.46	0.15	2.3
Total Assets	484.13	621.82	484.18	561.12	437.19	214.71
Accounts Payable	1.72	1.68	2.49	2.66	3.17	9.68
Accrued Expenses	28.33	26.23	23.29	12	7.6	4.64
Short-Term Debt	-	-	-	0.18	-	-
Current Portion of Leases	1.19	1.3	1.44	1.42	-	-
Current Income Taxes Payable	-	-	-	4.28	-	-
Other Current Liabilities	1.52	1.44	0.91	1.96	0.97	-
Total Current Liabilities	32.76	30.65	28.14	22.5	11.75	14.32
Long-Term Leases	-	0.85	2.15	3.59	-	-
Other Long-Term Liabilities	-	-	-	-	0.07	0.07
Total Liabilities	32.76	31.5	30.29	26.09	11.81	14.39
Common Stock	0.01	0.01	0	0.01	0	0
Additional Paid-In Capital	987.8	958.7	654.69	585.32	584.71	292.35
Retained Earnings	-537.41	-368.24	-200.86	-47.7	-158.91	-93.34
Comprehensive Income & Other	0.97	-0.13	-0.13	-2.6	-0.84	-0
Total Common Equity	451.37	590.33	453.7	535.03	424.97	199.01
Minority Interest	-	-	0.19	-	0.4	1.3
Shareholders' Equity	451.37	590.33	453.9	535.03	425.37	200.31
Total Liabilities & Equity	484.13	621.82	484.18	561.12	437.19	214.71
Total Debt	1.19	2.15	3.59	5.19	-	-
Net Cash (Debt)	331.41	396.83	463.48	462.1	290.47	210.21
Net Cash Growth	-42.43%	-14.38%	0.30%	59.09%	38.18%	113.13%
Net Cash Per Share	5.63	7.38	11.15	9.91	6.74	10.57
Filing Date Shares Outstanding	59.08	58.51	43.07	39.33	44.61	43.52
Total Common Shares Outstanding	59.08	58.51	42.9	45.8	44.29	2.02
Working Capital	309.48	384.02	452.05	451.97	284.82	197.96
Book Value Per Share	7.64	10.09	10.58	11.68	9.59	98.36
Tangible Book Value	451.37	590.33	453.7	535.03	424.97	199.01
Tangible Book Value Per Share	7.64	10.09	10.58	11.68	9.59	98.36
Machinery	-	0.77	0.77	0.68	0.2	0.2
Leasehold Improvements	-	0.58	0.58	0.63	0.11	0.11

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q